25.10.2021 • NewsBioNTechMerck

BioNTech Founders in German Research Hall of Fame

Özlem Türeci and Uğur Şahin, founders and managing board members of Mainz-based BioNTech, were inducted into the Hall of Fame of German Research (Hall of Fame der deutschen Forschung) on Oct. 21. The awards ceremony in Wiesbaden, Germany, was organized by German pharmaceuticals, chemicals and life sciences group Merck together with Manager Magazin.

The principals of the company that developed the first mRNA-based Covid-19 vaccine to be approved by regulatory authorities worldwide have done outstanding research for decades and are true pioneers in medicine, Merck CEO Belén Garijo said at the ceremony. “Based on this technology, she said, “the door to an effective treatment of cancer and to new vaccines for infectious diseases is now wide open. Their work has been indispensable in bringing the Covid-19 pandemic to a halt.”

Author: Dede Williams, Freelance Journalist

 

Özlem Türeci and Uğur Şahin, founders and managing board members of Covid...
Özlem Türeci and Uğur Şahin, founders and managing board members of Covid vaccine maker BioNTech, were inducted into the Hall of Fame of German Research on Oct. 21. The awards were presented by German pharmaceuticals, chemicals and life sciences group Merck and Manager Magazin. (c) Merck Group

Company

Merck KGaA

Frankfurter Str. 250
64293 Darmstadt
Germany

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.